Publication | Closed Access

Prevalence of dyslipidaemia in patients treated with lipid-lowering agents in China: Results of the DYSlipidemia International Study (DYSIS)

Metabolic SyndromeLipid DisorderCardiovascular DiseaseGlobal HealthDiabetesLipid DisordersInternational HealthHyperlipidemiaLipid-lowering AgentsDyslipidemiaLipoprotein MetabolismPublic HealthDyslipidemia International StudyEpidemiologyHealth Sciences